Recensioni verificate Soddisfatta del servizio.
Personale disponibile e gentile. Lo consiglio a tutti ...
Cliente Sorgente Genetica
logomysorgente

02  4948  5291

  • Cos'è AURORA

    Aurora è il test di screening prenatale di ultima generazione 
    sicuro, affidabile,
    veloce e precoce

  • Sicuro

    Grazie a un semplice prelievo di sangue materno
    eviti il rischio di aborto di tecniche invasive come amniocentesi o villocentesi

  • Affidabile

    Oltre il 99,9% di affidabilità nel rilevare
    la trisomia 21, responsabile
    della Sindrome di Down

  • Precoce e veloce

    icona svegliaIndividuare precocemente la presenza di anomalie cromosomiche è fondamentale:
    puoi effettuare Aurora dalla 10ª settimana

    icona documentoIl test è veloce: risultati in 7-10 giorni lavorativi con la percentuale di test da ripetere più bassa del mercato: 0,1%

  • La serenità della mamma
    in 3 semplici passi

    icotelefona

    Prenota il test

    icoesami

    Fai un prelievo di sangue

    icoginecologo

    Leggi i risultati

  • Test diagnosi prenatale non invasivo
  • 151126 banner Aurora mobile 01
  • 151126 banner Aurora mobile 02
  • 151126 banner Aurora mobile 03
  • slide mobile03
cover cartoon
cover venturetti

Ultime notizie dal mondo della genetica


More genetic tests for Lynch syndrome, more lives saved

Genetic tests for Lynch syndrome could save thousands of people. Unfortunately, the hospitals that perform them are still too few, at least in the United Kingdom. It is estimated that 8 out of 10 British hospitals are ignorant of official guidelines.

Those suffering from Lynch's syndrome have 80% more chance of developing bowel cancer. The genetic anomaly makes standard therapies less effective and therefore requires more energetic treatments. For this reason, British hospitals should carry out a genetic test to all those diagnosed with bowel cancer. In fact, in most cases this does not happen.

It is estimated that there are 175,000 carriers of the Lynch syndrome gene in the United Kingdom. Many of these do not know this and, in the case of cancer, they risk wasting time on unnecessary treatments. The genetic test would allow to identify the anomaly in the early stages of the tumor and to act accordingly.

The Bowel Cancer UK Association investigated how many hospitals follow the guidelines set up by the National Institute for Health and Care Excellence. According to the data collected, 83% of the facilities do not carry out genetic tests for Lynch syndrome where it is needed. A very serious fact, considering that only 5% of people with Lynch syndrome are aware of it.

According to the study, in 91% of cases the lack is due to the absence of funds. In second place there is the absence of qualified staff, followed by the lack of knowledge of the guidelines.

Source: telegraph.co.uk

Link social

Link social